Hasil Pencarian - Xenia Geeraerts
- Menampilkan 1 - 3 hasil dari 3
-
1
Intratumoral administration of the immunologic adjuvant AS01B in combination with autologous CD1c (BDCA-1)+/CD141 (BDCA-3)+ myeloid dendritic cells plus ipilimumab and intravenous... oleh Bart Neyns, Julia Katharina Schwarze, Karen Willard-Gallo, Ramses Forsyth, Jens Tijtgat, Sandra Tuyaerts, Ivan Van Riet, Steven Raeymaeckers, Xenia Geeraerts, Latoya Stevens, Manon Vounckx, Iris Dirven, Anais Boisson
Diterbitkan 2024-01-01
Artikel -
2
694 A randomized phase II clinical trial of SBRT and pembrolizumab with or without intratumoral avelumab/ipilimumab plus CD1c(BDCA-1)+/CD141(BDCA-3)+ myeloid dendritic cells in sol... oleh Bart Neyns, Bart Ilsen, Jens Tijtgat, Frederik Vandenbroucke, Inès Dufait, Sandra Tuyaerts, Ivan Van Riet, Xenia Geeraerts, Latoya Stevens, Manon Vounckx, Iris Dirven, Steven Raemaeckers, Selma Ben Mustapha, Jens Van Loon, Lore Decoster, Mark De Ridder
Diterbitkan 2023-11-01Artikel -
3
The tumour microenvironment harbours ontogenically distinct dendritic cell populations with opposing effects on tumour immunity oleh Damya Laoui, Jiri Keirsse, Yannick Morias, Eva Van Overmeire, Xenia Geeraerts, Yvon Elkrim, Mate Kiss, Evangelia Bolli, Qods Lahmar, Dorine Sichien, Jens Serneels, Charlotte L. Scott, Louis Boon, Patrick De Baetselier, Massimiliano Mazzone, Martin Guilliams, Jo A. Van Ginderachter
Diterbitkan 2016-12-01
Artikel